Mattocks v. Novartis Pharmaceuticals Corporation
| Thurston Mattocks |
| Novartis Pharmaceuticals Corporation |
| 4:2023cv00046 |
| March 13, 2023 |
| US District Court for the Eastern District of North Carolina |
| Terrence W Boyle |
| Kimberly A Swank |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1332 Diversity-Product Liability |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 11, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 13 CONDITIONAL TRANSFER ORDER (CTO - 7) - Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. 1407 to the Middle District of Florida for the reasons stated in the order of August 10, 2021, and, with the consent of that court, assigned to the Honorable Roy B. Dalton, Jr. Signed by John W. Nichols, Clerk of the Panel, entered on 5/11/2023. (Stouch, L.) |
| Case transferred to the Middle District of Florida. File transmitted electronically. (Stouch, L.) |
| Notice to Counsel regarding: #8 Notice of Special Appearance, #10 Notice of Special Appearance, #9 Notice of Special Appearance. Each attorney must file his or her own notice of appearance. The CM/ECF electronic filing and docketing system does not recognize filings made on behalf of other attorneys for purposes of appearing on the court's docket. The appropriate form for becoming a registered e-filer in this district is available to out-of-district counsel on this court's website www.nced.uscourts.gov. (Sellers, N.) |
| Filing 12 SUMMONS Returned Executed by Thurston Mattocks. Novartis Pharmaceuticals Corporation served on 3/28/2023, answer due 4/18/2023. (Beeson, Emily) |
Filing 11
ORDER FOR DISCOVERY PLAN sent to all parties. Signed by Peter A. Moore, Jr., Clerk of Court on 4/21/2023. (Stouch, L.)
|
| Case Selected for Mediation - A printable list of certified mediators for the Eastern District of North Carolina is available on the court's Website, http://www.nced.uscourts.gov/attorney/mediators.aspx. (Stouch, L.) |
| Filing 10 Notice of Special Appearance for non-district by Kelly Brooks Jones on behalf of Novartis Pharmaceuticals Corporation. (Jones, Kelly) |
| Filing 9 Notice of Special Appearance for non-district by Kelly Brooks Jones on behalf of Novartis Pharmaceuticals Corporation. (Jones, Kelly) |
| Filing 8 Notice of Special Appearance for non-district by Kelly Brooks Jones on behalf of Novartis Pharmaceuticals Corporation. (Jones, Kelly) |
| Filing 7 Financial Disclosure Statement by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis Corporation, Corporate Parent Novartis Financial Corporation, Corporate Parent Novartis Holdings, AG, Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation. (Jones, Kelly) |
| Filing 6 ANSWER to #1 Complaint, with Jury Demand by Novartis Pharmaceuticals Corporation. (Jones, Kelly) |
| Filing 5 Notice of Appearance filed by Kelly Brooks Jones on behalf of Novartis Pharmaceuticals Corporation. (Jones, Kelly) |
| Filing 4 Summons Issued as to Novartis Pharmaceuticals Corporation. (*NOTICE: Counsel shall print the attached summons and serve with other case opening documents in accordance with Fed.R.Civ.P. 4.*) (Rudd, D.) |
| Filing 3 Financial Disclosure Statement by Thurston Mattocks (Beeson, Emily) |
| Filing 2 Notice of Appearance filed by Emily J. Beeson on behalf of Thurston Mattocks. (Beeson, Emily) |
| NOTICE OF DEFICIENCY regarding [1-3] Financial Disclosure Statement. The Financial Disclosure statement is a stand alone document therefore Counsel is directed to refile the Financial Disclosure Statement using the event "OtherDocuments - Financial Disclosure Statement. (Rudd, D.) |
| Notice to Counsel regarding: [1-3] Financial Disclosure Statement. Counsel is reminded that the filing user must lock or flatten the PDF document. Failure to flatten documents may result in the clerks office issuing a notice of deficiency. Counsel should "flatten" (the financial disclosure statement) prior to attaching it in accordance with Section IV.B of the CM/ECF Policies and Procedures Manual. No further action is needed. (Rudd, D.) |
| Filing 1 COMPLAINT AND DEMAND FOR JURY TRIAL against Novartis Pharmaceuticals Corporation ( Filing fee $ 402 receipt number ANCEDC-6987336.), filed by Thurston Mattocks. (Attachments: #1 Civil Cover Sheet, #2 Proposed Summons, #3 Financial Disclosure Form) (Beeson, Emily) (Attachment 3 flattened and replaced on 3/15/2023) (Edwards, S.). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
| Search for this case: Mattocks v. Novartis Pharmaceuticals Corporation | |
|---|---|
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
| Plaintiff: Thurston Mattocks | |
| Represented By: | Emily J. Beeson |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Defendant: Novartis Pharmaceuticals Corporation | |
| Represented By: | Kelly Brooks Jones |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
